Drug Development in Pre-Clinical Research

Before testing a drug in people, researchers must determine whether it's the potential to cause serious harm, also called toxicity. the 2 sorts of preclinical research are: In Vitro, In Vivo. Usually, preclinical studies aren't very large. However, these studies must provide detailed information on dosing and toxicity levels. After preclinical testing, researchers review their findings and choose whether the drug should be tested in people.

 

    Related Conference of Drug Development in Pre-Clinical Research

    March 09-10, 2023

    3rd World Conference on Aerospace Engineering

    Dublin, Ireland
    April 17-18, 2023

    35th Nano Congress for Future Advancements

    Paris, France
    June 26-27, 2023

    40th Global Summit on Nanoscience and Technology

    Tokyo, Japan
    July 05-06, 2023

    40th Global Nanotechnology Congress

    Paris, France
    August 14-15, 2023

    26th World Nanotechnology Congress

    Dublin, Ireland
    September 27-28, 2023

    32nd International Conference on Nanomedicine & Drug Delivery

    Zurich, Switzerland
    October 16-17, 2023

    34th World Nano Conference

    Vancouver, Canada
    November 08-09, 2023

    4th World Congress on Nanotechnology and Advanced Materials

    Budapest, Hungary
    December 04-05, 2023

    31st International Conference on Nanomedicine and Nanomaterials

    Prague, Czech Republic

    Drug Development in Pre-Clinical Research Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in